Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer [1]

British Journal of Cancer

Volumn 96, Issue 8, 2007, Pages 1309-

  Span, P N ^a   Bussink, J ^a   De Mulder, P H ^a   Sweep, F C G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; HYPOXIA INDUCIBLE FACTOR 1;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; GENE OVEREXPRESSION; HUMAN; HYPOXIA; LETTER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT RESPONSE;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARBONIC ANHYDRASES; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247218067     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603715     Document Type: Letter

References (2)

1. Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH (2007) Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer 96: 104-109; doi:10.1038/sj.bjc.6603530
2. Span PN, Bussink J, Manders P, Beex LVAM, Sweep CGJ (2003) Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br J Cancer 89: 271-276; doi:10.1038/sj.bjc.6601122